Tempo Therapeutics reported raising $14 Million in an initial SEC Form D filing, from an offering of $14.5 Million
Amount Raised
$14 Million
Round Type
Venture
San DiegoBiotechnologyInvestors
Description
Tempo Therapeutics, a San Diego, CA-based regenerative medicine company, raised $14.5M in funding. Backers included Galaxy Sirius Partners, Johnson & Johnson Innovation – JJDC, Inc., and other new and existing investors. The company intends to use the funds to expand operations and its R&D efforts. Tempo Therapeutics develops synthetic biomaterials designed to promote the formation of healthy, functional tissue.
Quick answer
Tempo Therapeutics raised $14 Million in a funding round, dated August 27, 2026. Investors: YK Bioventures, Mesa Verde Venture Partners, Gideon Strategic Partners, Johnson & Johnson Innovation – Jjdc, Inc. and Galaxy Sirius Partners. Tempo Therapeutics is based in San Diego, California, United States.
- How much did Tempo Therapeutics raise?
- Tempo Therapeutics raised $14 Million in a funding round on August 27, 2026.
- Who invested in Tempo Therapeutics?
- YK Bioventures, Mesa Verde Venture Partners, Gideon Strategic Partners, Johnson & Johnson Innovation – Jjdc, Inc. and Galaxy Sirius Partners are named as investors in this round.
- What does Tempo Therapeutics do?
- Tempo Therapeutics, headquartered in San Diego, California, is pioneering a new era in tissue engineering biotechnology, using our proprietary MAP material science technology.
- Where is Tempo Therapeutics based and how big is it?
- Tempo Therapeutics is based in San Diego, California, United States. Fundz records about 15 employees.
- Who are the decision-makers at Tempo Therapeutics?
- Fundz holds 3 contacts at Tempo Therapeutics, including the Chief of Staff. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Tempo Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Matter Machine raised $5.3M (Pre-Series A) on October 11, 2026.
- Precision Chroma raised $13M (Seed) on October 11, 2026.
- B-Arm Medical Technologies raised $496K (Pre-Series A) on October 10, 2026.
- CollPlant Biotechnologies Ltd raised $3.7M (Post-IPO Equity) on October 9, 2026.
- Atlas Atomics raised $400M (Series A) on October 9, 2026.
- SpectaCell raised $6.7M (Seed) on October 9, 2026.
Who to call at Tempo Therapeutics, and when
A new round usually means Tempo Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Tempo Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Tempo Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Tempo Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Tempo Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Tempo Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.